et al., The New England Journal of Medicine , 2023, 10.1056/NEJMoa2301972 Study Objective To evaluate the efficacy, safety, and dose-response effect of Retatrutide a triple GIP, GLP-1, and glucagon receptor agonist in adults with overweight and obesity
The 2024 NICE update was explicit on one point: do not rule out B12 deficiency just because the standard blood count looks normal
We recently published a blog on the benefits and side effects of AOD9604
Athletes and competition AOD-9604 is on the World Anti-Doping Agency Prohibited List under category S2.2 (peptide hormones, growth factors, related substances, and mimetics)
Purity: 99% Testing Methods: HPLC & Mass Spectrometry Net Peptide Content: Verified Appearance: Lyophilized peptide powder Each batch undergoes analytical verification to confirm peptide identity, purity, and net peptide content